IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Current Stem Cell Research and Therapy

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

2.13

h-Index

2024-2025

 65

Rank

2024-2025

 10990

SJR

2024-2025

 0.529

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Current Stem Cell Research and Therapy
Abbreviation Curr. Stem Cell Res. Ther.
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q3)
h-index 65
Overall Rank/Ranking 10990
SCImago Journal Rank (SJR) 0.529
Impact Score 2.13
Publisher Bentham Science Publishers
Country United Arab Emirates
ISSN 1574888X, 22123946
Best Quartile Q3
Coverage History 2006-2025




Aim and Scope


Current Stem Cell Research & Therapy publishes frontier reviews of high quality on all aspects of basic research on stem cells and their uses in clinical therapy. The journal is essential reading for all researchers and clinicians involved in stem cells.


About Current Stem Cell Research and Therapy


Current Stem Cell Research and Therapy is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q3). It is published by Bentham Science Publishers. The overall rank of Current Stem Cell Research and Therapy is 10990. According to SCImago Journal Rank (SJR), this journal is ranked 0.529. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 65. The best quartile for this journal is Q3.

The ISSN of Current Stem Cell Research and Therapy journal is 1574888X, 22123946. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Stem Cell Research and Therapy is cited by a total of 507 articles during the last 3 years (Preceding 2024).


Current Stem Cell Research and Therapy Impact IF 2024-2025


The Impact IF 2024 of Current Stem Cell Research and Therapy is 2.13, which is computed in 2025 as per its definition. Current Stem Cell Research and Therapy IF is increased by a factor of 0.01 and approximate percentage change is 0.47% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Current Stem Cell Research and Therapy Impact IF 2025 Prediction


Impact IF 2024 of Current Stem Cell Research and Therapy is 2.13. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Current Stem Cell Research and Therapy. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 2.13
2023 2.12
2022 2.36
2021 3.01
2020 3.18
2019 2.34
2018 2.08
2017 1.64
2016 2.13
2015 2.81
2014 2.69

Current Stem Cell Research and Therapy h-index


  Table Setting

Current Stem Cell Research and Therapy has an h-index of 65. It means 65 articles of this journal have more than 65 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Current Stem Cell Research and Therapy ISSN


The ISSN of Current Stem Cell Research and Therapy is 1574888X, 22123946. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Current Stem Cell Research and Therapy Rank and SCImago Journal Rank (SJR)


The overall rank of Current Stem Cell Research and Therapy is 10990. According to SCImago Journal Rank (SJR), this journal is ranked 0.529. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Current Stem Cell Research and Therapy by Year


Year SJR
2025/2026 Coming Soon
2024 0.529
2023 0.525
2022 0.552
2021 0.572
2020 0.802
2019 0.577
2018 0.595
2017 0.543
2016 0.723
2015 0.886
2014 0.813

Ranking of Current Stem Cell Research and Therapy by Year


Year Ranking
2025/2026 Coming Soon
2024 10990
2023 10299
2022 9364
2021 8698
2020 6024
2019 8586
2018 8105
2017 8616
2016 6515
2015 5207
2014 5622

Current Stem Cell Research and Therapy Publisher


Table Setting

Current Stem Cell Research and Therapy is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Current Stem Cell Research and Therapy is Curr. Stem Cell Res. Ther.. This abbreviation ('Curr. Stem Cell Res. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Current Stem Cell Research and Therapy


If your research field is/are related to Medicine (miscellaneous) (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Current Stem Cell Research and Therapy?

Current Stem Cell Research and Therapy latest impact IF is 2.13. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.18 (2020) and 1.64 (2017), respectively, in the last 11 years. Moreover, its average IS is 2.41 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Current Stem Cell Research and Therapy?

The Current Stem Cell Research and Therapy has an SJR (SCImago Journal Rank) of 0.529, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.886 in 2015 and the lowest being 0.525 in 2023. Furthermore, the average SJR of the Current Stem Cell Research and Therapy over the previous 11-year period stands at 2.41.


What's the latest h-index of the Current Stem Cell Research and Therapy?

The latest h-index of the Current Stem Cell Research and Therapy is 65.


Who's the publisher of the Current Stem Cell Research and Therapy?

The Current Stem Cell Research and Therapy is published by the Bentham Science Publishers, with its country of publication being the United Arab Emirates.


What's the current ranking of the Current Stem Cell Research and Therapy?

The Current Stem Cell Research and Therapy is currently ranked 10990 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 5207 in 2015 and its lowest position of 10990 in 2024.


What's the abbreviation or short name for the Current Stem Cell Research and Therapy?

The standard ISO4 abbreviation for the Current Stem Cell Research and Therapy is Curr. Stem Cell Res. Ther..


Is the "Current Stem Cell Research and Therapy" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Current Stem Cell Research and Therapy is classified as a journal that the Bentham Science Publishers publishes.


What's the scope or major areas of the Current Stem Cell Research and Therapy?

The Current Stem Cell Research and Therapy encompasses the following areas:

  • Medicine (miscellaneous)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Current Stem Cell Research and Therapy?

The Current Stem Cell Research and Therapy is assigned the following International Standard Serial Numbers (ISSN): 1574888X, 22123946.


What's the best quartile of the Current Stem Cell Research and Therapy?

The best quartile for the Current Stem Cell Research and Therapy is Q3 (2024).


What's the coverage history of the Current Stem Cell Research and Therapy?

The Current Stem Cell Research and Therapy coverage history can be summarized as follows: 2006-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Milan Journal of Mathematics journal 5131 Birkhauser Verlag Basel 31 0.74
Archives of Phytopathology and Plant Protection journal 16692 Taylor and Francis Ltd. 35 1.42
Educational Measurement: Issues and Practice journal 6760 Wiley-Blackwell Publishing Ltd 68 1.54
Exploration Geophysics journal 18330 Taylor and Francis Ltd. 52 0.90
Museum Management and Curatorship journal 10490 Routledge 43 2.06
Journal of Sociology journal 6357 SAGE Publications Ltd 66 2.82
Poljoprivreda journal 17375 Faculty of Agriculture in Osijek 16 1.31
Cardiovascular Journal of Africa journal 17934 Clinics Cardive Publishing (PTY)Ltd 44 0.69
Advanced Studies in Contemporary Mathematics (Kyungshang) (discontinued) journal 21650 Jangjeon Mathematical Society 34 0.28
Economics of Innovation and New Technology journal 4303 Routledge 71 5.22

Check complete list




Year wise Impact Score (IS) of Current Stem Cell Research and Therapy

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 2.13
2023 2.12
2022 2.36
2021 3.01
2020 3.18
2019 2.34
2018 2.08
2017 1.64
2016 2.13
2015 2.81
2014 2.69



Top Journals/Conferences in Medicine (miscellaneous)

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Research | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Nature Medicine
Nature Research | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Research | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United Kingdom

Annual Review of Pathology: Mechanisms of Disease
Annual Reviews Inc. | United States

Physiological Reviews
American Physiological Society | United States

See All